Amplifon S.p.A Net Acquisitions/Divestitures 2019-2024 | AMFPF
Amplifon S.p.A annual/quarterly net acquisitions/divestitures history and growth rate from 2019 to 2024. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
- Amplifon S.p.A net acquisitions/divestitures for the quarter ending September 30, 2024 were $-0.077B, a 57.64% increase year-over-year.
- Amplifon S.p.A net acquisitions/divestitures for the twelve months ending September 30, 2024 were $-0.188B, a 77.13% decline year-over-year.
- Amplifon S.p.A annual net acquisitions/divestitures for 2024 were $-0.208B, a 77.47% increase from 2023.
- Amplifon S.p.A annual net acquisitions/divestitures for 2023 were $-0.117B, a 31.75% increase from 2022.
- Amplifon S.p.A annual net acquisitions/divestitures for 2022 were $-0.089B, a 82.06% decline from 2021.
| Amplifon S.p.A Annual Net Acquisitions/Divestitures (Millions of US $) |
|
|---|---|
| 2024 | $-208 |
| 2023 | $-117 |
| 2022 | $-89 |
| 2021 | $-497 |
| 2020 | $-102 |
| 2019 | $-77 |
| 2018 | $-758 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.378B | $2.607B |
| Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.222B | 26.93 |
| CVS Health (CVS) | United States | $74.320B | 9.24 |
| Elevance Health (ELV) | United States | $63.147B | 8.49 |
| Cencora (COR) | United States | $56.296B | 19.58 |
| DiDi Global (DIDIY) | China | $26.168B | 27.80 |
| Labcorp Holdings (LH) | United States | $22.406B | 17.68 |
| Natera (NTRA) | United States | $19.262B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| ICON (ICLR) | Ireland | $15.748B | 15.15 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.835B | 0.00 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.801B | 33.88 |
| Solventum (SOLV) | United States | $12.791B | 13.54 |
| Revvity (RVTY) | United States | $12.019B | 20.68 |
| Viatris (VTRS) | United States | $10.974B | 3.77 |
| Avantor (AVTR) | United States | $9.547B | 13.87 |
| Sonic Healthcare (SKHHY) | Australia | $9.287B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.698B | 17.05 |
| HealthEquity (HQY) | United States | $8.162B | 35.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.502B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
| BrightSpring Health Services (BTSG) | United States | $3.632B | 33.32 |
| Sotera Health (SHC) | United States | $3.437B | 19.53 |
| Surgery Partners (SGRY) | United States | $2.693B | 35.02 |
| Organon (OGN) | United States | $2.618B | 2.78 |
| Concentras Parent (CON) | United States | $2.517B | 14.55 |
| GeneDx Holdings (WGS) | United States | $2.324B | 89.50 |
| Alignment Healthcare (ALHC) | United States | $2.303B | 0.00 |
| Progyny (PGNY) | United States | $1.972B | 43.40 |
| GoodRx Holdings (GDRX) | United States | $1.775B | 35.50 |
| Premier (PINC) | United States | $1.747B | 13.26 |
| PACS (PACS) | United States | $1.742B | 0.00 |
| Ardent Health (ARDT) | United States | $1.543B | 6.58 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.248B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.067B | 8.12 |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.857B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.750B | 7.03 |
| CareDx (CDNA) | United States | $0.715B | 11.16 |
| Embecta (EMBC) | United States | $0.665B | 4.48 |
| Nutex Health (NUTX) | United States | $0.532B | 8.05 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| SBC Medicals (SBC) | United States | $0.505B | 0.00 |
| Omada Health (OMDA) | $0.486B | 0.00 | |
| LifeMD (LFMD) | United States | $0.485B | 0.00 |
| So-Young (SY) | China | $0.480B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.55 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.349B | 28.71 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.287B | 0.00 |
| Beauty Health (SKIN) | United States | $0.231B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.187B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.083B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |